IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 222 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $190,251 | -22.7% | 19,756 | -14.6% | 0.00% | – |
| Q2 2023 | $246,178 | +2.6% | 23,137 | +1.4% | 0.00% | – |
| Q1 2023 | $240,003 | -3.2% | 22,814 | +14.0% | 0.00% | – |
| Q4 2022 | $247,999 | +17.5% | 20,016 | -1.4% | 0.00% | – |
| Q3 2022 | $211,000 | +29.4% | 20,307 | +43.2% | 0.00% | – |
| Q2 2022 | $163,000 | +7.9% | 14,184 | +17.9% | 0.00% | – |
| Q1 2022 | $151,000 | +29.1% | 12,031 | +19.1% | 0.00% | – |
| Q4 2021 | $117,000 | – | 10,098 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 1,520,000 | $19,562,000 | 18.54% |
| Sarissa Capital Management LP | 16,390,000 | $210,939,000 | 16.77% |
| Healthcare Value Capital, LLC | 200,000 | $2,574,000 | 5.13% |
| Camber Capital Management LP | 7,500,000 | $96,525,000 | 3.25% |
| 13D Management LLC | 650,455 | $8,371,000 | 2.88% |
| BRIDGER MANAGEMENT, LLC | 2,035,114 | $26,192,000 | 2.44% |
| Brown Capital Management | 18,484,759 | $237,899,000 | 1.80% |
| Healthcare Value Capital, LLC | 50,000 | $644,000 | 1.28% |
| Zebra Capital Management LLC | 53,359 | $687,000 | 0.80% |
| PRICE MICHAEL F | 520,000 | $6,692,000 | 0.74% |